Baxter Healthcare

Cefazolin Sodium

Manufacturer:

Baxter Healthcare

Cefazolin Sodium HCPCS:

J0689

HCPCS Code Descriptor:

Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg

Category:

J Code

Cefazolin Sodium NDCs:

00338-3508-41, 00338-3503-41

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Bag

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00338-3508-41, 00338-3503-41

About Cefazolin Sodium:

Cefazolin Sodium is an Antibiotic drug manufactured by Baxter Healthcare and administered via the Intravenous route of administration. The J Code: J0689 is aligned to the drug Cefazolin Sodium.

ACCESS PRICING AND MORE BY REGISTERING

J0689 Added Date:

January 1, 2023

J0689 Effective Date:

January 1, 2023

J0689 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cefazolin Sodium billing and coding information.
Our team did not identify a source for Cefazolin Sodium patient assistance information. Please reach out to our team if you feel that this is a mistake.
Cefazolin Sodium prescribing information can be found at the link below:
Information regarding Cefazolin Sodium’s side effects can be found at MedlinePlus